Visual evoked potentials and nitrous oxide-induced neuronal depression: Role for benzodiazepine receptors

British Journal of Anaesthesia

Volumn 77, Issue 4, 1996, Pages 522-525

  Dzoljic, M ^a   Erdmann, W ^b   Dzoljic, M R ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Anaesthetics gases, nitrous oxide; Hypnotics benzodiazepine, Ro15 4513; Monitoring, evoked potentials; Rat; Receptors, amino acid

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR INVERSE STIMULATING AGENT; NITROUS OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; NERVE CONDUCTION; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029797878     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/77.4.522     Document Type: Article

References (27)

1. Miller KW, Paton WDM, Smith EB, Smith RA. Physicochemical approaches to the mode of action of general anesthetics. Anesthesiology 1972; 36: 339-351.
2. Bishop BE, Laverty R. Dose-dependent reduction by Ro 15-4513 in mice of the effects of ethanol and some other general depressant drugs. European Journal of Pharmacology 1989; 162: 265-271.
3. Dolin SJ, Halsey MJ, Little HJ. Effects of the calcium channel activator Bay K 8644 on general anaesthetic potency in mice. British Journal of Pharmacology 1988; 94: 413-422.
4. 3H]MK-801 binding and reversal by glycine. Neuroscience Letters 1991; 132: 73-76.
5. + currents in cultured rat hippocam-pal neurones by three volatile anaesthetics. Journal of Physiology (London) 1992; 449: 279-293.
6. Facklam M, Schoch P, Haefely WE. Relationship between benzodiazepine receptor occupancy and potentiation of γ-amino butyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies. Journal of Pharmacology and Experimental Therapeutics 1992; 261: 1106-1112.
7. Suzdak PD, Schwartz RD, Skolnick P, Paul SM. Ethanol stimulates γ-amino butyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proceedings of the National Academy of Sciences USA 1986; 83: 4071-4075.
8. Galindo A. Effects of procaine, pentobarbital and halothane on synaptic transmission in the central nervous system. Journal of Pharmacology and Experimental Therapeutics 1969; 169: 185-195.
9. Weight FF, Lovinger DM, White G, Peoples RW. Alcohol and anesthetic actions on excitatory amino acid-activated ion channels. Annals of the New York Academy of Sciences 1991; 625: 97-106.
10. Puil E, el-Beheiry H, Baimbridge KG. Anesthetic effects on glutamate-stimulated increase in intraneuronal calcium. Journal of Pharmacology and Experimental Therapeutics 1990; 255: 955-961.
11. Hunt WA, Mullin MJ. Effects of ethanol exposure on brain sodium channels. Alcohol and Drug Research 1986; 6: 419-422.
12. Marks SS, Watson DL, Carpenter CL, Messing RO, Greenberg DA. Comparative effects of chronic exposure to ethanol and calcium channel antagonists on calcium channel antagonist receptors in cultured neural (PC 12) cells. Journal of Neurochemistry 1989; 53: 168-172.
13. Terrar DA. Structure and function of calcium channels and the actions of anaesthetics. British Journal of Anaesthesia 1993; 71: 39-46.
14. Suzdak PD, Glowa JR, Crawley JN, Schwanz RD, Skolnick P, Paul SM. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 1986; 234: 1243-1247.
15. Hoffman PL, Tabakoff B, Szabo G, Suzdak PD, Paul SM. Effect of an imidazobenzodiazepine, Ro 15-4513, on the incoordination and hypothermia produced by ethanol and pentobarbital. Life Sciences 1987; 41: 611-619.
16. Ticku MK, Kulkarni K. Molecular interactions of ethanol with GABAergic system and potential of Ro 15-4513 as an ethanol antagonist. Pharmacology, Biochemistry and Behavior 1988; 30: 501-510.
17. Koblin DD, Deady JE, Dong DE, Eger EI. Mice tolerant to nitrous oxide are also tolerant to alcohol. Journal of Pharmacology and Experimental Therapeutics 1980; 213: 309-312.
18. Sebel PS, Flynn PJ, Ingram DA, Effects of nitrous oxide on visual, auditory and somatosensory evoked potentials. British Journal of Anaesthesia 1984; 56: 1403-1407.
19. Huang C, Liu G, Hsiao C-F, Huang RH. Nitrous oxide inhibits auditory and visual responses of granule cells in the cerebellum. Brain Research 1991; 553: 129-134.
20. Dzoljic M, Rupreht J, Erdmann W, Stijnen TH, Briemen LJ, Dzoljic MR. Behavioral and electrophysiological aspects of nitrous oxide dependence. Brain Research Bulletin 1994; 33: 25-31.
21. Bigler ED. Neurophysiology, neuropharmacology and behavioral relationships of visual system evoked after-discharges. Biobehavioral Reviews 1977; 1: 95-112.
22. Berkowitz BA, Finck AD, Hynes MD, Ngai SH. Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology 1979; 51: 309-312.
23. Schubert A, Licina MG, Lineberry PJ. The effect of ketamine on human somatosensory evoked potentials and its modification by nitrous oxide. Anesthesiology 1990; 72: 33-39.
24. Franks NP, Lieb WR. Selective actions of volatile general anaesthetics at molecular and cellular levels. British Journal of Anaesthesia 1993; 71: 65-76.
25. Schwartz AE, Maneksha FR, Kanchuger MS, Sidhu US, Poppers PJ. Flumazenil decreases the minimum alveolar concentration of isoflurane in dogs. Anesthesiology 1989; 70: 764-766.
26. Moody EJ, Skolnick P. The imidazobenzodiazepine Ro15-4513 antagonizes methoxyflurane anesthesia. Life Sciences 1988; 43: 1269-1276.
27. Mandema JW, Gubbens-Stibbe JM, Danhof M. Stability and pharmacokinetics of flumazenil in the rat. Psychopharmacology 1991; 103: 384-387.